To the Editor: In Australia, the rising cost of the Pharmaceutical Benefits Scheme (a comprehensive system for subsidising prescription medicines for the whole population) has led to the Australian Government instituting a number of cost-saving strategies.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1 Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
- 2 Department of Pharmacy Practice, Victorian College of Pharmacy, Monash University, Melbourne, VIC.
Correspondence: azmihassali@usm.my
- 1. McGavock H. Generic substitution: issues relating to the Australian experience. Pharmacoepidemiol Drug Saf 2001; 10: 555-556.
- 2. Birkett DJ. Generics — equal or not? Aust Prescr 2003; 26: 85-87.
- 3. Salmivaara AH, Huupponen R, Klaukka T, Hoppu K. Focusing on changing clinical practice to enhance rational prescribing — collaboration and networking enable comprehensive approaches. Health Policy 2003; 66: 1-10.
- 4. Armstrong D, Reyburn H, Jones R. A study of general practitioners’ reasons for changing their prescribing behaviour. BMJ 1996; 312: 949-952.
- 5. Majumdar SR, Tsuyuki RT, McAlister FA. Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trial. Am Heart J 2007; 153: 22e1-22e8.
Online responses are no longer available. Please refer to our instructions for authors page for more information.